Over the years, we have developed formulations of 68 molecules in various therapeutics and have manufactured more than 400 brands for Indian market. Our Group has all the required expertise and know-how for developing all the dosage forms in addition to high ended skills and expertise in the NDDS, like CR/SR/ER tablets, Pegylated Liposome injections, Liposomal Injections, Depot Injections, etc.

Over the past 7 years, we launched a number of first generic formulations in India, such as Pegylated Liposomal Doxorubicin, Edaravone injection, Drosperinone + Ethinyl Estradiol Tabs, Caspofungin injection, Daptomycin injectection, Abiraterone Tabs, Everolimus Tabs, Fulvestrant inj, etc. We steadfastly maintains a robust and impressive growth rate of 50 per cent per annum.

For the overseas markets, our qualified & experienced marketing professionals analyze and screen partners and zero in on the best possible alliance, given the differing dynamics of the each individual market scenario and product basket, dosage forms, etc. are determined and finalized. To cater to such identified overseas markets, different mechanisms of promotion are deliberated and put into place, the most common being transfer of technology agreement under a confidentiality agreement, which allows us to commercialize the selected products with transparency with great comfort to our overseas partners. At the moment, we are nurturing several such partnerships to ensure market participation and steady growth world-wide.